Polypharmacy in the HIV-infected older adult population

Lauren J Gleason1, Amneris E Luque2, Krupa Shah1 1Division of Geriatrics and Aging, Highland Hospital, Rochester, NY, USA; 2Division of Infectious Disease, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Abstract: The prevalence of human immunode...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gleason LJ, Luque AE, Shah K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	HIV polypharmacy older adults geriatrics Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/fa7174f75b7244aaafb195ad5740a4ef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fa7174f75b7244aaafb195ad5740a4ef
record_format	dspace
spelling	oai:doaj.org-article:fa7174f75b7244aaafb195ad5740a4ef2021-12-02T02:25:05ZPolypharmacy in the HIV-infected older adult population1178-1998https://doaj.org/article/fa7174f75b7244aaafb195ad5740a4ef2013-06-01T00:00:00Zhttps://www.dovepress.com/polypharmacy-in-the-hiv-infected-older-adult-population-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Lauren J Gleason1, Amneris E Luque2, Krupa Shah1 1Division of Geriatrics and Aging, Highland Hospital, Rochester, NY, USA; 2Division of Infectious Disease, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Abstract: The prevalence of human immunodeficiency virus (HIV) infection among people older than 50 years is increasing. Older HIV-infected patients are particularly at risk for polypharmacy because they often have multiple comorbidities that require pharmacotherapy. Overall, there is not much known with respect to both the impact of aging on medication use in HIV-infected individuals, and the potential for interactions with highly active antiretroviral therapy (HAART) and coadministered medications and its clinical consequences. In this review, we aim to provide an overview of polypharmacy with a focus on its impact on the HIV-infected older adult population and to also provide some clinical considerations in this high-risk population. Keywords: HIV, older adults, polypharmacyGleason LJLuque AEShah KDove Medical PressarticleHIVpolypharmacyolder adultsgeriatricsGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 8, Pp 749-763 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	HIV polypharmacy older adults geriatrics Geriatrics RC952-954.6
spellingShingle	HIV polypharmacy older adults geriatrics Geriatrics RC952-954.6 Gleason LJ Luque AE Shah K Polypharmacy in the HIV-infected older adult population
description	Lauren J Gleason1, Amneris E Luque2, Krupa Shah1 1Division of Geriatrics and Aging, Highland Hospital, Rochester, NY, USA; 2Division of Infectious Disease, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Abstract: The prevalence of human immunodeficiency virus (HIV) infection among people older than 50 years is increasing. Older HIV-infected patients are particularly at risk for polypharmacy because they often have multiple comorbidities that require pharmacotherapy. Overall, there is not much known with respect to both the impact of aging on medication use in HIV-infected individuals, and the potential for interactions with highly active antiretroviral therapy (HAART) and coadministered medications and its clinical consequences. In this review, we aim to provide an overview of polypharmacy with a focus on its impact on the HIV-infected older adult population and to also provide some clinical considerations in this high-risk population. Keywords: HIV, older adults, polypharmacy
format	article
author	Gleason LJ Luque AE Shah K
author_facet	Gleason LJ Luque AE Shah K
author_sort	Gleason LJ
title	Polypharmacy in the HIV-infected older adult population
title_short	Polypharmacy in the HIV-infected older adult population
title_full	Polypharmacy in the HIV-infected older adult population
title_fullStr	Polypharmacy in the HIV-infected older adult population
title_full_unstemmed	Polypharmacy in the HIV-infected older adult population
title_sort	polypharmacy in the hiv-infected older adult population
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/fa7174f75b7244aaafb195ad5740a4ef
work_keys_str_mv	AT gleasonlj polypharmacyinthehivinfectedolderadultpopulation AT luqueae polypharmacyinthehivinfectedolderadultpopulation AT shahk polypharmacyinthehivinfectedolderadultpopulation
_version_	1718402506653958144

Polypharmacy in the HIV-infected older adult population

Ejemplares similares